| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |